Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma
- PMID: 2473044
- DOI: 10.1007/BF02550806
Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma
Abstract
Serum beta-HCG was elevated in 10 of 83 consecutive patients with histologically pure seminoma (12%). Six patients with diagnostic stage I were successfully treated by radiation therapy. One patient with state IIc suffered a mediastinal relapse following retroperitoneal radiotherapy. Two other patients with high tumour burden achieved complete remission after induction chemotherapy followed by surgery and radiotherapy, respectively. One patient with retroperitoneal bulky disease reached permanent complete remission after radiation therapy alone. Beta-HCG-positive seminomas constitute a distinct category of germ-cell tumours on the basis of morphological and clinical features. Corresponding to the intermediate histological position between seminoma and nonseminoma, safe treatment of beta-HCG-positive seminoma can be achieved by radiotherapy in stage I, by retroperitoneal lymphadenectomy plus adjuvant chemotherapy in stages IIa, b and by induction chemotherapy in stages IIc and III.
Similar articles
-
Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.J Urol. 1992 Apr;147(4):1041-3. doi: 10.1016/s0022-5347(17)37460-8. J Urol. 1992. PMID: 1372658
-
Postoperative reduction of serum beta-HCG in testicular seminoma.Int Urol Nephrol. 1988;20(3):281-6. doi: 10.1007/BF02549517. Int Urol Nephrol. 1988. PMID: 2456999
-
Seminoma with elevated human chorionic gonadotropin. The case for retroperitoneal lymph node dissection.Urology. 1985 Apr;25(4):344-6. doi: 10.1016/0090-4295(85)90482-0. Urology. 1985. PMID: 2580384
-
Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.Arch Ital Urol Androl. 2002 Jun;74(2):81-5. Arch Ital Urol Androl. 2002. PMID: 12161942 Review.
-
Treatment of seminoma.Semin Oncol. 1992 Apr;19(2):171-80. Semin Oncol. 1992. PMID: 1372759 Review. No abstract available.
Cited by
-
An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).Br J Cancer. 1991 Sep;64(3):537-42. doi: 10.1038/bjc.1991.346. Br J Cancer. 1991. PMID: 1716953 Free PMC article.
-
Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.Biomed Res Int. 2019 May 28;2019:5030349. doi: 10.1155/2019/5030349. eCollection 2019. Biomed Res Int. 2019. PMID: 31275973 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical